- Home
- STRO vs APUR Comparison
STRO vs APUR Comparison
Compare STRO & APUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | STRO | APUR |
|---|---|---|
| Founded | 2003 | 2025 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 181.4M | 146.9M |
| IPO Year | 2018 | 2025 |
Fundamental Metrics
Financial Performance| Metric | STRO | APUR |
|---|---|---|
| Price | $8.89 | $10.05 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 14 | 0 |
| Target Price | ★ $47.23 | N/A |
| AVG Volume (30 Days) | ★ 279.9K | 34.3K |
| Earning Date | 11-05-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $38,419,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.72 | $9.90 |
| 52 Week High | $43.85 | $10.13 |
Technical Indicators
Market Signals| Indicator | STRO | APUR |
|---|---|---|
| Relative Strength Index (RSI) | 21.28 | 66.56 |
| Support Level | N/A | $9.90 |
| Resistance Level | $16.99 | N/A |
| Average True Range (ATR) | 1.24 | 0.01 |
| MACD | -0.18 | -0.00 |
| Stochastic Oscillator | 7.84 | 27.27 |
Price Performance
Historical ComparisonAbout STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About APUR Aperture AC Class A Ordinary Shares
Aperture AC is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.